Clinical trial

Effect of Dapagliflozin in Patients With Acute Heart Failure (DAPA-RESPONSE-AHF)

NCT05406505

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-04-25

PhasePHASE2 / PHASE3

Study timeline

Study start (actual)2022-04-25Date precision: day

Registry last updated2023-08-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Acute Heart Failureunresolved

Interventions

Dapagliflozin 10mg TabDRUG

PlaceboOTHER

Sponsors & collaborators

Mansoura Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05406505 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.